136 related articles for article (PubMed ID: 20497246)
1. High expression level of geminin predicts a poor clinical outcome in salivary gland carcinomas.
Yamazaki M; Fujii S; Murata Y; Hayashi R; Ochiai A
Histopathology; 2010 Jun; 56(7):883-92. PubMed ID: 20497246
[TBL] [Abstract][Full Text] [Related]
2. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
[TBL] [Abstract][Full Text] [Related]
3. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland.
Okabe M; Inagaki H; Murase T; Inoue M; Nagai N; Eimoto T
Mod Pathol; 2001 Oct; 14(10):1008-14. PubMed ID: 11598171
[TBL] [Abstract][Full Text] [Related]
6. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis.
Lim JJ; Kang S; Lee MR; Pai HK; Yoon HJ; Lee JI; Hong SP; Lim CY
J Oral Pathol Med; 2003 Oct; 32(9):552-61. PubMed ID: 12969230
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.
Miyabe S; Okabe M; Nagatsuka H; Hasegawa Y; Inagaki A; Ijichi K; Nagai N; Eimoto T; Yokoi M; Shimozato K; Inagaki H
J Oral Maxillofac Surg; 2009 Jul; 67(7):1432-41. PubMed ID: 19531414
[TBL] [Abstract][Full Text] [Related]
9. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
Li SS; Xue WC; Khoo US; Ngan HY; Chan KY; Tam IY; Chiu PM; Ip PP; Tam KF; Cheung AN
Histopathology; 2005 Mar; 46(3):307-13. PubMed ID: 15720416
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic analysis of adenoid cystic carcinoma of major salivary glands of 64 cases].
Qing J; Zhang Q; Wei MW; Guo ZM
Ai Zheng; 2006 Sep; 25(9):1138-43. PubMed ID: 16965658
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of cell proliferation in major salivary gland carcinomas.
Suzzi MV; Alessi A; Bertarelli C; Cancellieri A; Procaccio L; Dall'olio D; Laudadio P
Acta Otorhinolaryngol Ital; 2005 Jun; 25(3):161-8. PubMed ID: 16450771
[TBL] [Abstract][Full Text] [Related]
12. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
Dudderidge TJ; Stoeber K; Loddo M; Atkinson G; Fanshawe T; Griffiths DF; Williams GH
Clin Cancer Res; 2005 Apr; 11(7):2510-7. PubMed ID: 15814627
[TBL] [Abstract][Full Text] [Related]
13. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression.
Gonzalez MA; Tachibana KE; Chin SF; Callagy G; Madine MA; Vowler SL; Pinder SE; Laskey RA; Coleman N
J Pathol; 2004 Oct; 204(2):121-30. PubMed ID: 15376260
[TBL] [Abstract][Full Text] [Related]
14. Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.
Press MF; Pike MC; Hung G; Zhou JY; Ma Y; George J; Dietz-Band J; James W; Slamon DJ; Batsakis JG
Cancer Res; 1994 Nov; 54(21):5675-82. PubMed ID: 7522962
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
Monteiro LS; Bento MJ; Palmeira C; Lopes C
J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor in salivary gland carcinomas correlates with lymph node metastasis.
Lequerica-Fernández P; Astudillo A; de Vicente JC
Anticancer Res; 2007; 27(5B):3661-6. PubMed ID: 17972532
[TBL] [Abstract][Full Text] [Related]
17. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.
Jaehne M; Roeser K; Jaekel T; Schepers JD; Albert N; Löning T
Cancer; 2005 Jun; 103(12):2526-33. PubMed ID: 15900577
[TBL] [Abstract][Full Text] [Related]
18. [The role of neck dissection in the eradication of salivary carcinomas].
Lin GC
Zhonghua Kou Qiang Yi Xue Za Zhi; 1991 May; 26(3):137-9, 190. PubMed ID: 1652411
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin expression in salivary gland carcinomas.
Bjørndal K; Larsen SR; Godballe C; Krogdahl A
J Oral Pathol Med; 2011 Jul; 40(6):451-5. PubMed ID: 20969634
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
Williams MD; Roberts D; Blumenschein GR; Temam S; Kies MS; Rosenthal DI; Weber RS; El-Naggar AK
Am J Surg Pathol; 2007 Nov; 31(11):1645-52. PubMed ID: 18059220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
